Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (21-30 of 368) with videos related to

Pageof 37
Sort By:
Nature Reviews. Gastroenterology & Hepatology|July 3, 2013
Epidemiology and natural history of HCV infectionBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|August 24, 2017
Direct-acting antiviral agents for HCV infection affecting people who inject drugsJason Grebely, Behzad Hajarizadeh, Gregory J Dore
Journal of Hepatology|July 23, 2008
The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposureGail V Matthews, Jason Grebely, Gregory J Dore
Canadian Liver Journal|August 22, 2022
Hepatitis C: A Canadian perspectiveNaglaa H Shoukry, Jordan J Feld, Jason Grebely
Nature Reviews. Gastroenterology & Hepatology|March 23, 2011
Treatment of acute HCV infectionJason Grebely, Gail V Matthews, Gregory J Dore
Journal of Hepatology|August 8, 2009
HCV reinfection studies and the door to vaccine developmentJason Grebely, David L Thomas, Gregory J Dore
The International Journal on Drug Policy|October 18, 2011
Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic reviewRachel Sacks-Davis, Danielle Horyniak, Jason Grebely, et al.
Nature Medicine|February 13, 2020
Global elimination of hepatitis C virus by 2030: why not?Gregory J Dore, Marianne Martinello, Maryam Alavi, et al.
Drug and Alcohol Review|May 23, 2012
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugsCarla Treloar, Peter Hull, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Markus Backmund, et al.
Pageof 37

Showing results (21-30 of 368) with videos related to

Sort By:
Pageof 37
Nature Reviews. Gastroenterology & Hepatology|July 3, 2013
Epidemiology and natural history of HCV infectionBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|August 24, 2017
Direct-acting antiviral agents for HCV infection affecting people who inject drugsJason Grebely, Behzad Hajarizadeh, Gregory J Dore
Journal of Hepatology|July 23, 2008
The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposureGail V Matthews, Jason Grebely, Gregory J Dore
Canadian Liver Journal|August 22, 2022
Hepatitis C: A Canadian perspectiveNaglaa H Shoukry, Jordan J Feld, Jason Grebely
Nature Reviews. Gastroenterology & Hepatology|March 23, 2011
Treatment of acute HCV infectionJason Grebely, Gail V Matthews, Gregory J Dore
Journal of Hepatology|August 8, 2009
HCV reinfection studies and the door to vaccine developmentJason Grebely, David L Thomas, Gregory J Dore
The International Journal on Drug Policy|October 18, 2011
Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic reviewRachel Sacks-Davis, Danielle Horyniak, Jason Grebely, et al.
Nature Medicine|February 13, 2020
Global elimination of hepatitis C virus by 2030: why not?Gregory J Dore, Marianne Martinello, Maryam Alavi, et al.
Drug and Alcohol Review|May 23, 2012
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugsCarla Treloar, Peter Hull, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Moving the agenda forward: the prevention and management of hepatitis C virus infection among people who inject drugsJason Grebely, Philip Bruggmann, Markus Backmund, et al.
Pageof 37